+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Medical Polymer Market Size, Share & Trends Analysis Report by Product, by Application (Medical Device Packaging, Tooth Implants, Wound Care, Mobility Aids, Denture-based Materials), by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 170 Pages
  • April 2022
  • Region: Global
  • Grand View Research
  • ID: 4538786
The global medical polymer market size is expected to reach USD 36.8 billion by 2030, registering a CAGR of 8.0%. The industry is expected to register growth due to the high adoption of polymers in implants on account of their chemical inertness and superior fatigue resistance. The demand for medical device packaging is likely to be driven by the rise in the demand for in-house and advanced medical devices.



In addition, a high level of consumer expenditure on healthcare, primarily in the U.S., China, and Germany, is expected to drive the application segment in the forthcoming years. Moreover, rising positive coronavirus cases across the globe are positively influencing the demand for medical devices, thereby propelling the demand for medical polymers.

Raw materials used for medical polymers include ethylene, propylene, caprolactam, corn starch, and silica stone (SiO2). Silica stone is the most significant component found in the Earth's crust and is derived from sand mining and the purification of quartz. It is used in the production of silicone elastomers, which are widely used in the medical industry. Corn starch is used in the production of biodegradable polymers such as polylactic acid (PLA) and polyhydroxyalkanoates (PHA).

Medical Polymer Market Report Highlights

  • In terms of revenue, medical components application accounted for a market share in 2021 and is further expected to witness prominent growth over the forecast period.
  • Medical Components dominated the market and accounted for more than 40.0% of the revenue share in 2021 owing to the lightweight, high bacterial, and chemical resistance properties provided by the polymers.
  • As of 2021, North America accounted for more than 40.0% revenue share in the overall market due to increasing per capita healthcare spending in the form of health insurance in the U.S and the rapid growth of pharmaceutical industries in Mexico and Canada.
  • Major players are continuously working on expanding manufacturing capabilities with the rise in demand from the medical industry. In July 2021, Celanese Corporation announced the expansion of its Florence, Kentucky research and development center with the addition of a pharmaceutical drug delivery feasibility lab.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope and Assumptions
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Third-Party Perspective
1.3.5 Primary Research
1.4 Information Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation and Data Visualization
1.6 Data Validation and Publishing
1.7 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Summary
2.2 Market Segmental Outlook
Chapter 3 Medical Polymers Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Global Polymers Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Medical Polymers Market: Industry Value Chain Analysis
3.3.1 Raw Material Trends
3.3.1.1 Caprolactam (Nylon Polymer Fibers)
3.3.1.2 Ethylene (Polyethylene Resins, Polypropylene Resins, Polyester Fibers, and EPDM Rubber)
3.4 Manufacturing Trends
3.4.1 Polyethylene
3.4.1.1 High Pressure Process
3.4.1.2 Low Pressure Process
3.4.2 Polylactic Acid (PLA)
3.4.3 Ethylene Propylene Diene Monomer Rubber (EPDM)
3.5 Technology Overview
3.6 Regulatory Framework
3.6.1 Standards &Million Compliances
3.6.1.1 Restriction of Hazardous Substances (RoHS) Directive, 2011/65/EU
3.6.1.2 Packaging and Packaging Waste Directive, 94/62/EC
3.6.1.3 REACH Regulation, No. 1907/2006
3.6.1.4 CE Mark
3.6.1.5 Proposed Regulation in Europe
3.6.2 Safety
3.6.2.1 Hazards Identification
3.6.2.2 First-Aid Measures
3.6.2.3 Fire-Fighting Measures
3.7 Medical Polymers Market: Market Dynamics
3.7.1 Market Driver Analysis
3.7.1.1 Growth of the medical industry
3.7.1.2 Rise in global healthcare expenditure
3.7.2 Market Restraint Analysis
3.7.2.1 Stringent government regulations
3.7.3 Market Opportunity Analysis
3.7.4 Biodegradable Polymers Use in Medical Application
3.7.5 Market Challenge Analysis
3.7.5.1 Growing concerns over waste management
3.8 Industry Analysis: Bio-Based Polyurethane Market
3.8.1 Porter’s Five Forces Analysis
3.8.2 PESTEL Analysis
Chapter 4 Medical Polymers Market: Product Estimates & Trend Analysis
4.1 Medical Polymers Market: Product Movement Analysis, 2021 & 2030
4.2 Fibers & Resins
4.2.1 Medical polymers market estimates and forecasts, by fiber & resins, 2019-2030 (Kilotons) (USD Million)
4.3 Medical Elastomers
4.3.1 Medical polymers market estimates and forecasts, by medical elastomers, 2019-2030 (kilotons) (USD Million)
4.4 Biodegradable Polymers
4.4.1 Medical polymers market estimates and forecasts, by medical elastomers, 2019-2030 (Kilotons) (USD Million)
4.4.1.1 Medical polymers market estimates and forecasts, by polylactic acid (PLA), 2019-2030 (Kilotons) (USD Million)
4.4.1.2 Medical polymers market estimates and forecasts, by polylactic acid (PLA), 2019-2030 (Kilotons) (USD Million)
4.5 Others
4.5.1 Medical polymers market estimates and forecasts, by others, 2019-2030 (Kilotons) (USD Million)
Chapter 5 Medical Polymers Market: Application Estimates & Trend Analysis
5.1 Medical Polymers Market: Application Movement Analysis, 2021 & 2030
5.2 Medical Device Packaging
5.2.1 Medical polymers market estimates and forecasts, in medical device packaging, 2019-2030 (Kilotons) (USD Million)
5.3 Medical Components
5.3.1 Medical polymers market estimates and forecasts, in medical components, 2019-2030 (Kilotons) (USD Million)
5.4 Cleanroom Supplies
5.4.1 Medical polymers market estimates and forecasts, in cleanroom supplies, 2019-2030 (Kilotons) (USD Million)
5.5 Orthopedic Soft Goods
5.5.1 Medical polymers market estimates and forecasts, in orthopedic soft goods, 2019-2030 (Kilotons) (USD Million)
5.6 Wound Care
5.6.1 Medical polymers market estimates and forecasts, in wound care, 2019-2030 (Kilotons) (USD Million)
5.7 BioPharm Devices
5.7.1 Medical polymers market estimates and forecasts, in biopharm devices, 2019-2030 (Kilotons) (USD Million)
5.8 Sterilization and Infection Prevention
5.8.1 Medical polymers market estimates and forecasts, in sterilization and infection prevention, 2019-2030 (Kilotons) (USD Million)
5.9 Mobility Aids
5.9.1 Medical polymers market estimates and forecasts, in mobility aids, 2019-2030 (Kilotons) (USD Million)
5.10 Tooth Implants
5.10.1 Medical polymers market estimates and forecasts, in tooth implants, 2019-2030 (Kilotons) (USD Million)
5.11 Denture Base Materials
5.11.1 Medical polymers market estimates and forecasts, in denture-based materials, 2019-2030 (Kilotons) (USD Million)
5.12 Other Implants
5.12.1 Medical polymers market estimates and forecasts, in other implants, 2019-2030 (Kilotons) (USD Million)
5.13 Others
5.13.1 Medical polymers market estimates and forecasts, in others, 2019-2030 (Kilotons) (USD Million)
Chapter 6 Medical Polymers Market: Regional Estimates & Trend Analysis
6.1 Medical Polymers Market: Regional Movement Analysis & Market Share, 2021 & 2030
6.2 Europe
6.2.1 Europe medical polymers market estimates and forecasts, 2019-2030 (Kilotons) (USD Million)
6.2.2 Europe medical polymers market estimates and forecasts, by product, 2019-2030 (Kilotons) (USD Million)
6.2.3 Europe medical polymers market estimates and forecasts, by application, 2019-2030 (Kilotons) (USD Million)
6.2.4 U.K.
6.2.4.1 U.K. medical polymers market estimates and forecasts, 2019-2030 (Kilotons) (USD Million)
6.2.4.2 U.K. medical polymers market estimates and forecasts, by product, 2019-2030 (Kilotons) (USD Million)
6.2.4.3 U.K. medical polymers market estimates and forecasts, by application, 2019-2030 (Kilotons) (USD Million)
6.2.5 Germany
6.2.5.1 Germany medical polymers market estimates and forecasts, 2019-2030 (Kilotons) (USD Million)
6.2.5.2 Germany medical polymers market estimates and forecasts, by product, 2019-2030 (Kilotons) (USD Million)
6.2.5.3 Germany medical polymers market estimates and forecasts, by application, 2019-2030 (Kilotons) (USD Million)
6.2.6 France
6.2.6.1 France medical polymers market estimates and forecasts, 2019-2030 (Kilotons) (USD Million)
6.2.6.2 France medical polymers market estimates and forecasts, by product, 2019-2030 (Kilotons) (USD Million)
6.2.6.3 France medical polymers market estimates and forecasts, by application, 2019-2030 (Kilotons) (USD Million)
6.2.7 Italy
6.2.7.1 Italy medical polymers market estimates and forecasts, 2019-2030 (Kilotons) (USD Million)
6.2.7.2 Italy medical polymers market estimates and forecasts, by product, 2019-2030 (Kilotons) (USD Million)
6.2.7.3 Italy medical polymers market estimates and forecasts, by application, 2019-2030 (Kilotons) (USD Million)
6.3 Asia Pacific
6.3.1 Asia Pacific medical polymers market estimates and forecasts, 2019-2030 (Kilotons) (USD Million)
6.3.2 Asia Pacific medical polymers market estimates and forecasts, by product, 2019-2030 (Kilotons) (USD Million)
6.3.3 Asia Pacific medical polymers market estimates and forecasts, by application, 2019-2030 (Kilotons) (USD Million)
6.3.4 China
6.3.4.1 China medical polymers market estimates and forecasts, 2019-2030 (Kilotons) (USD Million)
6.3.4.2 China medical polymers market estimates and forecasts, by product, 2019-2030 (Kilotons) (USD Million)
6.3.4.3 China medical polymers market estimates and forecasts, by application, 2019-2030 (Kilotons) (USD Million)
6.3.4.4 India medical polymers market estimates and forecasts, 2019-2030 (Kilotons) (USD Million)
6.3.4.5 India medical polymers market estimates and forecasts, by product, 2019-2030 (Kilotons) (USD Million)
6.3.4.6 India medical polymers market estimates and forecasts, by application, 2019-2030 (Kilotons) (USD Million)
6.3.5 Japan
6.3.5.1 Japan medical polymers market estimates and forecasts, 2019-2030 (Kilotons) (USD Million)
6.3.5.2 Japan medical polymers market estimates and forecasts, by product, 2019-2030 (Kilotons) (USD Million)
6.3.5.3 Japan medical polymers market estimates and forecasts, by application, 2019-2030 (Kilotons) (USD Million)
6.3.6 Malaysia
6.3.6.1 Malaysia medical polymers market estimates and forecasts, 2019-2030 (Kilotons) (USD Million)
6.3.6.2 Malaysia medical polymers market estimates and forecasts, by product, 2019-2030 (Kilotons) (USD Million)
6.3.6.3 Malaysia medical polymers market estimates and forecasts, by application, 2019-2030 (Kilotons) (USD Million)
6.3.7 Singapore
6.3.7.1 Singapore medical polymers market estimates and forecasts, 2019-2030 (Kilotons) (USD Million)
6.3.7.2 Singapore medical polymers market estimates and forecasts, by product, 2019-2030 (Kilotons) (USD Million)
6.3.7.3 Singapore medical polymers market estimates and forecasts, by application, 2019-2030 (Kilotons) (USD Million)
6.3.8 Oceania
6.3.8.1 Oceania medical polymers market estimates and forecasts, 2019-2030 (Kilotons) (USD Million)
6.3.8.2 Oceania medical polymers market estimates and forecasts, by product, 2019-2030 (Kilotons) (USD Million)
6.3.8.3 Oceania medical polymers market estimates and forecasts, by application, 2019-2030 (Kilotons) (USD Million)
6.4 Central & South America
6.4.1 Central & South America medical polymers market estimates and forecasts, 2019-2030 (Kilotons) (USD Million)
6.4.2 Central & South America medical polymers market estimates and forecasts, by product, 2019-2030 (Kilotons) (USD Million)
6.4.3 Central & South America medical polymers market estimates and forecasts, by application, 2019-2030 (Kilotons) (USD Million)
6.4.4 Brazil
6.4.4.1 Brazil medical polymers market estimates and forecasts, 2019-2030 (Kilotons) (USD Million)
6.4.4.2 Brazil medical polymers market estimates and forecasts, by product, 2019-2030 (Kilotons) (USD Million)
6.4.4.3 Brazil medical polymers market estimates and forecasts, by application, 2019-2030 (Kilotons) (USD Million)
6.4.5 Argentina
6.4.5.1 Argentina medical polymers market estimates and forecasts, 2019-2030 (Kilotons) (USD Million)
6.4.5.2 Argentina medical polymers market estimates and forecasts, by product, 2019-2030 (Kilotons) (USD Million)
6.4.5.3 Argentina medical polymers market estimates and forecasts, by application, 2019-2030 (Kilotons) (USD Million)
6.5 Middle East & Africa
6.5.1 Middle East & Africa medical polymers market estimates and forecasts, 2019-2030 (Kilotons) (USD Million)
6.5.2 Middle East & Africa medical polymers market estimates and forecasts, by product, 2019-2030 (Kilotons) (USD Million)
6.5.3 Middle East & Africa medical polymers market estimates and forecasts, by application, 2019-2030 (Kilotons) (USD Million)
6.5.3.1 Saudi Arabia
6.5.3.2 Saudi Arabia medical polymers market estimates and forecasts, 2019-2030 (Kilotons) (USD Million)
6.5.3.3 Saudi Arabia medical polymers market estimates and forecasts, by product, 2019-2030 (Kilotons) (USD Million)
6.5.3.4 Saudi Arabia medical polymers market estimates and forecasts, by application, 2019-2030 (Kilotons) (USD Million)
6.5.3.5 South Africa
6.5.3.6 South Africa medical polymers market estimates and forecasts, 2019-2030 (Kilotons) (USD Million)
6.5.3.7 South Africa medical polymers market estimates and forecasts, by product, 2019-2030 (Kilotons) (USD Million)
6.5.3.8 South Africa medical polymers market estimates and forecasts, by application, 2019-2030 (Kilotons) (USD Million)
Chapter 7 Competitive Analysis
7.1 Key Global Players & Recent Developments and Their Impact on the Industry
7.2 Key Company/Competition Categorization (Key Innovators, Market Leaders, and Emerging Players)
7.3 List of Biopolymer Manufacturers in Malaysia
7.4 Vendor landscape
7.4.1 List of Key Distributors
7.4.2 List of Key End User
7.5 Competitive Dashboard Analysis
Chapter 8 Company Profiles
8.1 BASF SE
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Product Benchmarking
8.1.4 Strategic Initiative
8.2 NatureWorks LLC
8.2.1 Company Overview
8.2.2 Product Benchmarking
8.2.3 Strategic Initiative
8.3 Covestro AG
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Product Benchmarking
8.3.4 Strategic Initiative
8.4 Celanese Corporation
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Product Benchmarking
8.4.4 Strategic initiative
8.5 Eastman Chemical Corporation
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Product Benchmarking
8.5.4 Strategic Initiative
8.6 Evonik Industries AG
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Product Benchmarking
8.6.4 Strategic Initiative
8.7 Dow Inc.
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Product Benchmarking
8.7.4 Strategic Initiative
8.8 Exxon Mobil Corporation
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Product Benchmarking
8.8.4 Strategic Initiative
8.9 Arkema
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.9.4 Strategic Initiative
8.10 Koninklijke DSM NV
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Product Benchmarking
8.10.4 Strategic Initiative
8.11 Formosa Plastics Corporation
8.11.1 Company Overview
8.11.2 Financial Performance
8.11.3 Product Benchmarking
8.12 Foryou Medical
8.12.1 Company Overview
8.12.2 Product Benchmarking
8.13 KRATON CORPORATION
8.13.1 Company Overview
8.13.2 Financial Performance
8.13.3 Product Benchmarking
8.13.4 Strategic Initiative
8.14 SABIC
8.14.1 Company Overview
8.14.2 Financial Performance
8.14.3 Product Benchmarking
8.14.4 Strategic Initiative
8.15 Trinseo S.A.
8.15.1 Company Overview
8.15.2 Financial Performance
8.15.3 Product Benchmarking
8.15.4 Strategic Initiative

Companies Mentioned

  • Basf Se
  • Natureworks LLC
  • Covestro AG
  • Celanese Corporation
  • Eastman Chemical Corporation
  • Evonik Industries AG
  • Dow Inc.
  • Exxon Mobil Corporation
  • Arkema
  • Koninklijke Dsm Nv
  • Formosa Plastics Corporation
  • Foryou Medical
  • Kraton Corporation
  • Sabic
  • Trinseo S.A.

Methodology

Loading
LOADING...

Table Information